India, Sept. 22 -- Decoy Therapeutics Inc. (DCOY) is up 101.56 percent, gaining $2.62 to $5.18 on Tuesday. The move comes after the biotechnology company announced an expanded strategy to develop its Designable Multi-Antivirals for additional viral threats, including a pan-filovirus program targeting Ebola and Marburg viruses under the U.S. Food and Drug Administration's Animal Rule pathway.
Decoy Therapeutics is currently trading at $5.18, up from the previous close of $2.56 after opening at $5.26 on the Nasdaq. The stock has traded between $4.82 and $7.61 during the session, with trading volume at 89.09 million shares versus average volume of 255,339 shares.
The company said a first-generation de novo filovirus candidate demonstrated lo...